Literature DB >> 9640555

Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders.

M A Gupta1, A K Gupta, G N Watteel.   

Abstract

Touch is a powerful medium of social validation. Patients with skin disorders often experience social rejection when people avoid touching them, possibly fearing contagion or filth. We examined the psychologic impact of the stigma experience among 137 patients with moderate to severe psoriasis; 26.3 percent of patients reported that during the previous month they had experienced an episode when "people made a conscious effort not to touch them" because of their psoriasis. The stigmatized group did not have greater psoriasis severity than the non-stigmatized control group. However, in contrast to the non-stigmatized group, the stigmatized group had higher (P = 0.0003) depression scores (in the range for clinical depression, as measured by the Carroll Rating Scale for Depression), by stepwise logistic regression analysis using a wide range of psychopathologic measures as the independent variables. These findings underline the profound impact of the stigma experience in psoriasis, and possibly other dermatologic conditions that are associated with social stigma.

Entities:  

Mesh:

Year:  1998        PMID: 9640555

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  12 in total

Review 1.  The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.

Authors:  Emmilia A Dowlatshahi; Marlies Wakkee; Lidia R Arends; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2013-11-27       Impact factor: 8.551

2.  Psychological Distress, Alexithymia and Alcohol Misuse in Patients with Psoriasis: A Cross-Sectional Study.

Authors:  Ourania Founta; Karoline Adamzik; Anne-Marie Tobin; Brian Kirby; David Hevey
Journal:  J Clin Psychol Med Settings       Date:  2019-06

3.  Acupuncture combined with herbal medicine versus herbal medicine alone for plaque psoriasis: a systematic review protocol.

Authors:  Shiju Xiao; Bo Li; Shuo Feng; Cunzhi Liu; Guangzhong Zhang
Journal:  Ann Transl Med       Date:  2019-03

4.  Social support and adaptation to the disease in men and women with psoriasis.

Authors:  Konrad Janowski; Stanisława Steuden; Aldona Pietrzak; Dorota Krasowska; Lukasz Kaczmarek; Ilona Gradus; Grażyna Chodorowska
Journal:  Arch Dermatol Res       Date:  2012-03-29       Impact factor: 3.017

5.  Relationship Between Skin Shame, Psychological Distress and Quality of Life in Patients with Psoriasis: a Pilot Study.

Authors:  Donja Homayoon; Michaela Hiebler-Ragger; Moritz Zenker; Wolfgang Weger; Human Unterrainer; Elisabeth Aberer
Journal:  Acta Derm Venereol       Date:  2020-07-02       Impact factor: 3.875

6.  Psoriasis and psycho-dermatology.

Authors:  Hee-Sun Moon; Alexandra Mizara; Sandy R McBride
Journal:  Dermatol Ther (Heidelb)       Date:  2013-07-10

Review 7.  Psoriasis and comorbidities: links and risks.

Authors:  Catherine Ni; Melvin W Chiu
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-04-17

8.  Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial.

Authors:  J-P Ortonne; M Esposito; S Chimenti; M Kapińska-Mrowiecka; A Grodzińska; L Naldi; V Frangione
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-10-29       Impact factor: 6.166

9.  Self-management in daily life with psoriasis: an integrative review of patient needs for structured education.

Authors:  Gitte Susanne Rasmussen; Helle Terkildsen Maindal; Kirsten Lomborg
Journal:  Nurs Res Pract       Date:  2012-12-06

10.  Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011.

Authors:  April W Armstrong; Clayton Schupp; Julie Wu; Bruce Bebo
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.